Skip to main content
OpenTrials

Clinical trial condition

Gram-Positive Bacterial Infections

Explore clinical trials studying Gram-Positive Bacterial Infections. Study availability and eligibility vary by location and protocol.

2,601 public trials 262 recruiting studies
Refine in advanced search Browse all conditions

Gram-Positive Bacterial Infections trial results

Completed

Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age

NCT03642847

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • Collaborative Neuroscience Network, LLC. Garden Grove, California, United States
  • Collaborative Neuroscience Network, LLC. Long Beach, California, United States
  • East-West Medical Research Institute Honolulu, Hawaii, United States
  • Clinilabs Drug Development Corporation Eatontown, New Jersey, United States
View Trial Details
Completed

Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults

NCT00385255

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +13 more
Locations
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View Trial Details
Completed

Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

NCT00370396

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Jarvenpaa, Finland
View all 35 locations
View Trial Details
Completed

Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)

NCT01716533

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Clostridium Infections, +3 more
Locations
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Houston, Texas, United States
  • GSK Investigational Site Hamilton, Ontario, Canada
View Trial Details
Completed

Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants

NCT01204658

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations
  • GSK Investigational Site Benešov, Czechia
  • GSK Investigational Site Brno, Czechia
  • GSK Investigational Site Děčín, Czechia
  • GSK Investigational Site Jindřichův Hradec, Czechia
View all 24 locations
View Trial Details

Related conditions